Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of military academy patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11623024 Cell sheet construct for neurovascular reconstruction and manufacture thereof	Patent 11623024 was granted and assigned to National Defense Medical Center on April, 2023 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	11623024	April 11, 2023
‌ US Patent 11439730 Cell sheet construct for neurovascular reconstruction and manufacture thereof		National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	11439730	September 13, 2022
‌ US Patent 7820386 Cancer screening method	Patent 7820386 was granted and assigned to National Defense Medical Center on October, 2010 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	7820386	October 26, 2010
‌ US Patent 8097274 Skin substitutes, preparation methods and uses thereof	Patent 8097274 was granted and assigned to National Defense Medical Center on January, 2012 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8097274	January 17, 2012
‌ US Patent 8414938 None	Patent 8414938 was granted and assigned to National Defense Medical Center on April, 2013 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8414938	April 9, 2013
‌ US Patent 8993637 Use of citral for treating focal segmental glomerulosclerosis	Patent 8993637 was granted and assigned to National Defense Medical Center on March, 2015 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	8993637	March 31, 2015
‌ US Patent 9321795 Use of hydroxycinnamaldehyde glycoside derivatives for treating glomerulonephritis	Patent 9321795 was granted and assigned to National Defense Medical Center on April, 2016 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	9321795	April 26, 2016
‌ US Patent 9393234 Pharmaceutical compositions and methods for treating cancer and biomarkers for drug screening	Patent 9393234 was granted and assigned to National Defense Medical Center on July, 2016 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	9393234	July 19, 2016
‌ US Patent 9393226 Use of osthole for treating focal segmental glomerulosclerosis	Patent 9393226 was granted and assigned to National Defense Medical Center on July, 2016 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	9393226	July 19, 2016
‌ US Patent 9018203 Pharmaceutical composition of salicylanilide-derived small molecules and preparation and application thereof	Patent 9018203 was granted and assigned to National Defense Medical Center on April, 2015 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	9018203	April 28, 2015
‌ US Patent 9489491 Portable and modular prescription drug dispensing device	Patent 9489491 was granted and assigned to Norwich University on November, 2016 by the United States Patent and Trademark Office.	Norwich University	Norwich University	United States Patent and Trademark Office	9489491	November 8, 2016
‌ US Patent 8975255 Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives	Patent 8975255 was granted and assigned to National Defense Medical Center on March, 2015 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8975255	March 10, 2015
‌ US Patent 9415034 Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)	Patent 9415034 was granted and assigned to National Defense Medical Center on August, 2016 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	9415034	August 16, 2016
‌ US Patent 10526398 Anti-dengue virus antibodies and applications thereof	Patent 10526398 was granted and assigned to National Defense Medical Center on January, 2020 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	10526398	January 7, 2020
‌ US Patent 10537664 Cell sheet construct for neurovascular reconstruction and manufacture thereof	Patent 10537664 was granted and assigned to National Defense Medical Center on January, 2020 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	10537664	January 21, 2020
‌ US Patent 8927717 Thiochromeno[2,3-	Patent 8927717 was granted and assigned to National Defense Medical Center on January, 2015 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	8927717	January 6, 2015
‌ US Patent 9566010 Method for detecting cardiac status, method for monitoring cardiac status during exercise, and apparatus for monitoring cardiac status	Patent 9566010 was granted and assigned to National Defense Medical Center on February, 2017 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	9566010	February 14, 2017
‌ US Patent 8173648 1,2,3,4-tetrahydroisoquinoline derivatives, preparation process therefor and pharmaceutical composition containing the same	Patent 8173648 was granted and assigned to National Defense Medical Center on May, 2012 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8173648	May 8, 2012
‌ US Patent 8178358 Serpine2 as a biomarker for IgA nephropathy	Patent 8178358 was granted and assigned to National Defense Medical Center on May, 2012 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8178358	May 15, 2012
‌ US Patent 8877748 Heterocyclic fused anthraquinone derivatives, manufacturing method and pharmaceutical composition using thereof	Patent 8877748 was granted and assigned to National Defense Medical Center on November, 2014 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	8877748	November 4, 2014
‌ US Patent 9162993 Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives	Patent 9162993 was granted and assigned to National Defense Medical Center on October, 2015 by the United States Patent and Trademark Office.	National Defense Medical Center	National Defense Medical Center	United States Patent and Trademark Office	9162993	October 20, 2015
‌ US Patent 8053583 Anti-cancer compound and manufacturing method thereof	Patent 8053583 was granted and assigned to National Defense Medical Center on November, 2011 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8053583	November 8, 2011
‌ US Patent 8785137 Method for renal disease diagnosis using Rab23 as marker	Patent 8785137 was granted and assigned to National Defense Medical Center on July, 2014 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8785137	July 22, 2014
‌ US Patent 8222287 Substituted anthra[1,2-D]imidazolediones and pharmaceutical utility thereof	Patent 8222287 was granted and assigned to National Defense Medical Center on July, 2012 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8222287	July 17, 2012
‌ US Patent 8445492 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds	Patent 8445492 was granted and assigned to National Defense Medical Center on May, 2013 by the United States Patent and Trademark Office.		National Defense Medical Center	United States Patent and Trademark Office	8445492	May 21, 2013

Results per page:

45 results

0 selected

45 results

0 selected